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Summary We examined the effects of citric acid and L-carnitine administration on physical
fatigue. In a double-blind, placebo-controlled, 3-way crossover study, 18 healthy volunteers
were randomized to oral citric acid (2,700 mg/day), L-carnitine (1,000 mg/day), or placebo for
8 days. The fatigue-inducing physical task consisted of workload trials on a cycle ergometer
at fixed workloads for 2 h on 2 occasions. Before the physical load, salivary chromogranin A,
measured as a physiological stress marker, was lower in the group given citric acid than in the
group given placebo. Also, after the physical load, the subjective feeling of fatigue assessed
with a visual analogue scale was lower in the citric acid group than in the placebo group. In
contrast,  L-carnitine had no effect on chromogranin A or subjective fatigue. These results
suggest that citric acid reduces physiological stress and attenuates physical fatigue, whereas
L-carnitine does not.
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Introduction
Fatigue is a common symptom both in sickness and in
health [1–3]. Chronic or accumulated fatigue can affect an
individual’s performance. In addition, long-term accumulated
fatigue can lead to Karoshi (death as a result of overwork).
Recently, there has been a great increase in the use of over-the-
counter supplements and naturally occurring nutraceuticals for
the attenuation of fatigue [4]. However, there are no established
treatment recommendations for fatigue. One reason for this
has been the lack of standardized fatigue-inducing tasks or
appropriate methods for objective quantification of fatigue.
Fatigue is best defined as difficulty in initiating or sustaining
voluntary activities [5]. It can be subdivided into physical
and mental fatigue. Recently, we succeeded in developing
physical and mental fatigue-inducing tests and in developing
some methods for evaluating physical and mental fatigue by
several biomarkers. By using those, we sought to evaluate the
effects of two candidate anti-fatigue substances on physical
fatigue.
Muscular exercise causes rapid adenosine triphosphate
(ATP) consumption, and energy deficiency is an important
factor in fatigue [6]. Thus, exogenous dietary substances that
can lead to ATP production are considered to be candidate
anti-physical fatigue materials.
Citric acid is a key player in the tricarboxylic acid (TCA)
cycle [7], which is part of a metabolic pathway involved in
the chemical conversion of carbohydrates, fats, and proteins
into carbon dioxide and water to generate energy. TCA cycle
intermediates decrease in fatigue during prolonged exercise [8].
Indeed, citric acid administration is expected to activate the
TCA cycle and also the subsequent oxidative phosphorylation
in mitochondria and thereby increase the production of ATP.
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This may reduce physical fatigue if energy deficiency is a
cause of fatigue. Before hydroxycitric acid (HCA) was a
promising anti-fatigue substance by inhibiting ATP citrate lyase
with citric acid [9], but recently it was reported Garcinia
cambogia containing HCA had reproductive toxicity [10,
11], so citric acid is superior to HCA as an anti-fatigue
substance in the respect of toxicity.
On the other hand, L-carnitine transports long-chain fatty
acids across the inner mitochondrial membranes in the
mitochondria, where they are processed by beta-oxidation to
produce biological energy in the form of ATP [12]. It has
been reported that the serum L-carnitine level is low in some
chronic fatigue patients, and L-carnitine administration is
used to treat some patients with chronic fatigue syndrome
[13, 14].
The aim of this study was to investigate the effects of two
candidate anti-fatigue substances involved in fuel metabolism,
citric acid and L-carnitine, on physical fatigue, using recently




Eighteen healthy volunteers, whose background is
summarized in Table 1, were enrolled in this double-blind,
randomized, placebo-controlled, 3-way crossover trial. The
participants were recruited using an advertisement. Current
smokers, subjects with a history of medical illness, subjects
taking chronic medication or supplemental vitamins, subjects
with a body weight less than 40 kg, and subjects who had
donated blood within one month before the study or had a
blood hemoglobin level less than 12.0 g/dl were excluded.
The participants’ health status was assessed through physical
examination and laboratory examinations, including an electro-
cardiogram, chest X-ray, blood chemistry panel (glucose,
hemoglobin A1c, creatinine, blood urea nitrogen, sodium,
potassium, chloride, uric acid, asparate aminotransferase,
alanine aminotransferase, gamma-glutamyl transpeptidase,
and creatine phosphokinase), lipid profile (total cholesterol
and triglyceride), complete blood count, and urinalysis. The
protocol was approved by the Ethics Committee of Soiken Inc.
and Soiken Clinic; all subjects gave their written informed
consent.
Experimental design
After enrollment, the subjects were randomized into 3
groups to receive the following treatments twice a day for
one week before the experimental day in a double-blind
fashion: 5 capsules of citric acid [270 mg of citric acid (Fuso
Chemical Co., Ltd., Osaka, Japan) and 100 mg of crystalline
cellulose (JRS Pharma GmbH & Co. KG, Rosenberg,
Germany)],  L-carnitine [146.2 mg of L-carnitine tartrate
(100 mg as free L-carnitine) (Nissin Pharma Inc., Tokyo,
Japan) and 153.8 mg crystalline cellulose]; or placebo
[230 mg of crystalline cellulose]. The doses of citric acid
and L-carnitine were based on previous human studies [13–
15]. The day before each test day, subjects finished dinner by
8:00 p.m. and then fasted overnight. The subjects were not
allowed to bathe. The next morning at 7:15 a.m., the subjects
were asked to subjectively rate their fatigue level; blood
pressure and heart rate were measured; and blood samples
were collected. Thereafter, the subjects had breakfast [75 g
glucose solution (TRELAN-G 75, Shimizu Pharma, Shizuoka,
Japan)] and 5 capsules of placebo, citric acid, or L-carnitine.
The fatigue-inducing physical task consisted of workload
trials on a cycle ergometer (Aerobike 75XL2 ME; Combi
Wellness Co., Tokyo, Japan) at fixed workloads to reach
80% of the heart rate at the anaerobic threshold for 2 h, as
described previously [16]. This task was repeated twice in
each (placebo-, citric acid-, or L-carnitine) arm of the study.
The physical test began at 8:10 a.m.; blood pressure was
measured every 30 min. Just after the end of the first task
section at 10:10 a.m., subjects were asked to subjectively
rate their fatigue. After the end of the last task section at 0:25
p.m., subjects were again asked to subjectively rate their
fatigue; blood pressure and heart rate were measured, and
blood samples were collected. At 1:30 p.m., the subjects had
lunch. After lunch, to recover from fatigue, the subjects read
books or magazines, listened to music, or talked until 4:30
p.m. After the end of the recovery period, the subjects were
again asked to subjectively rate their fatigue; blood pressure
and heart rate were measured, and blood samples were
collected. During the experiment, the subjects could only
take water and the specified meals. All participants had the
same dinner before the test day and the same lunch on the test
day. The tests were conducted in a quiet, temperature- and
humidity-controlled environment. For 1 week before each
test, subjects refrained from strenuous physical activity and
followed their normal diets, as well as their normal drinking
and sleeping patterns. The time interval between each test
was set at 4 weeks to take into account the female subjects’
menstrual cycles.
Visual analogue scale
The subjects were asked to subjectively rate their fatigue
level on a visual analogue scale (VAS) from 0 (no fatigue) to
100 (total exhaustion) before, during, and after physical
Table 1. Subject Background
No. Subjects 18 (9 men, 9 women)
Age (years) 36.1 ± 9.9 (between 21 and 57)
Height (cm) 165.1 ± 7.7
Body weight (kg) 61.4 ± 7.8
BMI (kg/m2) 22.5 ± 2.6T. Sugino et al.
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exertion and after the recovery period. The VAS was origi-
nally developed for measuring pain level [17] and has been
used for fatigue level [18].
Physical performance test
During the physical performance test, the subjects were
asked to perform 10 s maximum speed trial using a cycle
ergometer at 30 min (30-min trial) after the start and 30 min
before the end of the test (210-min trial). The torque of each
subject was calculated as 8.5% of the body weight for male
subjects and 7.5% of the body weight for female subjects.
Blood sample analyses
Blood samples were collected from the brachial vein. To
assess serum total protein (TP), blood urea nitrogen (BUN),
creatine phosphokinase (CPK), aspartate aminotransferase
(AST), lactate dehydrogenase (LDH), triglyceride (TG), free
fatty acids, ketone bodies (acetoacetic acid, 3-hydroxybutyric
acid), cortisol, citric acid, L-carnitine, and acyl-carnitine, the
blood samples were centrifuged at 1,700 g for 10 min at 4°C.
The blood samples used to determine the plasma glucose
levels were collected in a fluorosodium-containing tube and
centrifuged at 1,700 g for 10 min at 4°C. The blood samples
used to determine plasma adrenocorticotropic hormone
(ACTH) were collected in an ethylenediamine-N,N,N',N'-
tetraacetic acid, disodium salt-containing tube and kept on
ice until centrifuged at 1,700 g for 10 min at 4°C. The blood
samples used to determine blood lactate were collected in a
0.8 N perchloric acid-containing tube and kept on ice until
centrifuged at 1,700 g for 5 min at 4°C. All of the supernatants
were stored at −80°C until analyzed. Assays of serum
cortisol and plasma ACTH assays were performed by radio-
immunoassay at Special Reference Laboratories (SRL;
Tokyo, Japan), and serum CPK, AST, LDH, free fatty acids,
citric acid, plasma glucose and blood lactate levels measured
by general procedure, L-carnitine and acyl-carnitine levels by
enzymatic cycling method at Sakai Bio-clinical Laboratory,
Inc. (Osaka, Japan).
Saliva sample analyses
Saliva samples were collected using Salivett (Sarstedt
Akiengesellscaft & Co.). To access salivary chromogranin A
and total protein, the saliva samples were centrifuged at
1,700 g for 10 min at 4°C. All of the samples were stored
at  −30°C until analyzed. Assay of chromogranin A was
performed by enzyme-linked immunosorbent assay at
Yanaihara Institute Inc. (Shizuoka, Japan); the total protein
assay was performed by Bradford method at Soiken Inc.
(Osaka, Japan).
Statistical analyses
The values are shown as mean ± SD. Paired t tests with the
Bonferroni correction were used to evaluate the significance
of differences between the placebo and citric acid groups,
and between the placebo and L-carnitine groups. All p values
were 2-tailed; p values less than 0.05 were considered to be
statistically significant.
Results
Subjective feelings and physiological and biochemical
parameters after citric acid and L-carnitine administration are
summarized in Table 2. The VAS score for fatigue in the
citric acid group was lower than in the placebo group at the
end of the physical load. The score in the placebo group was
74.6, so the task of 4 hr Physical load could induce over 70%
of full exhaustion in daily life. Mean body weight, systolic
blood pressure, diastolic blood pressure, heart rate, and
biochemical parameters (serum TP, BUN, CPK, AST, and
LDH) did not differ among the three groups at any examination
points.
Metabolic and hormonal parameters after citric acid and
L-carnitine administration are summarized in Table 3. The
three groups did not differ with respect to plasma glucose,
blood lactate level, serum triglyceride, free fatty acids,
ketone bodies, cortisol, plasma ACTH or serum citric acid
levels at any examination points. However, before the
physical load, the salivary chromogranin A level was lower
in the citric acid group than in the placebo group. Also,
serum  L-carnitine and acyl-carnitine levels were higher in
the  L-carnitine group than in the placebo group before the
physical load, at the end of the physical load, and after the
recovery period.
The performance of the three groups during the physical
tests is summarized in Table 4. There were no significant
differences among the three groups in the maximum speed
of rotation in 10 s.
Discussion
Acute fatigue is a physiological phenomenon that disappears
after a certain period of rest. In contrast, however, long-term
fatigue sometimes causes irreversible damages, and the
function that is useful in reducing acute fatigue is no longer
effective.
In order to assess the effect of substances on physical
fatigue, it is important to evaluate the subjects’ physical
performance. In this study, we performed 10 s maximum
speed trials using a cycle ergometer during the fatigue-
inducing physical tests. However, neither citric acid
(2,700 mg/day) nor L-carnitine (1,000 mg/day) could improve
physical performance during fatigue-inducing workload
tests on a cycle ergometer. This negative result may be
relevant to the length of the performance tests: 10 s. Support
for this comes from the fact that it takes 8 s for maximum
exercise to deplete the ATP pool in muscle cells. PerformanceCitric acid, L-carnitine and physical fatigue
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tests done for a longer period of time may possibly give
different results.
On the other hand, we found that oral administration of
citric acid for 8 days improved the subjective feeling of
fatigue during fatigue-inducing workload trials on a cycle
ergometer. The VAS scores after 4 hr physical load were
60.6 in the citric acid group and 74.6 in the placebo group.
The difference of VAS score, 14.0 is so large that almost all
people feel the fatigue reduction in daily life. Although these
anti-fatigue effects were observed rather chronically, the
increase in serum citric acid level appeared to be transient. The
serum citric acid levels, when measured only two hours after
the final administration of citric acid, did not show any rise in
the citric acid group, which is consistent with its previously
reported rapid absorption and metabolism [19]. Therefore, it
remains to be elucidated how the transient increase in serum
citric acid levels can lead to the continuously observed anti-
fatigue effect.
In addition to subjective improvement of the feeling of
fatigue, we also observed that citric acid administration for
Table 2. Effects of citric acid and L-carnitine on subjective feeling of fatigue and physiological and
biochemical parameters
Before (0 h) After (4 h) Recovery (8 h)
VAS for fatigue Placebo 31.0 ± 19.7 74.6 ± 13.2 59.0 ± 20.5
Citric acid 22.2 ± 15.6 60.6 ± 13.5** 50.1 ± 16.8
L-Carnitine 31.2 ± 17.0 73.4 ± 14.1 65.4 ± 16.3
Body weight (kg) Placebo 61.5 ± 7.7 61.0 ± 7.5 61.8 ± 7.6
Citric acid 61.3 ± 8.1 60.9 ± 8.0 61.6 ± 8.0
L-Carnitine 61.5 ± 8.1 61.0 ± 7.8 61.1 ± 7.6
SBP (mmHg) Placebo 118 ± 13 117 ± 12 120 ± 13
Citric acid 113 ± 9 115 ± 9 118 ± 10
L-Carnitine 115 ± 13 113 ± 10 115 ± 14
DBP (mmHg) Placebo 70 ± 9 65 ± 7 70 ± 9
Citric acid 69 ± 6 65 ± 7 69 ± 6
L-Carnitine 70 ± 10 64 ± 6 70 ± 10
HR (bpm) Placebo 70 ± 10 89 ± 12 85 ± 10
Citric acid 71 ± 8 88 ± 9 84 ± 8
L-Carnitine 72 ± 8 89 ± 11 85 ± 8
TP (g/dL) Placebo 7.4 ± 0.5 7.7 ± 0.4 7.2 ± 0.7
Citric acid 7.5 ± 0.4 7.5 ± 0.4 7.2 ± 0.6
L-Carnitine 7.5 ± 0.4 7.8 ± 0.3 7.2 ± 0.4
BUN (mg/dL) Placebo 12.5 ± 2.9 12.0 ± 2.5 12.1 ± 3.3
Citric acid 12.8 ± 3.3 12.1 ± 2.7 12.3 ± 2.9
L-Carnitine 12.8 ± 2.9 12.7 ± 3.2 13.3 ± 4.2
CPK (IU/L) Placebo 85 ± 25 126 ± 69 178 ± 183
Citric acid 88 ± 31 108 ± 42 141 ± 91
L-Carnitine 91 ± 30 112 ± 40 120 ± 37
AST (IU/L) Placebo 18 ± 5 20 ± 5 18 ± 6
Citric acid 18 ± 3 20 ± 6 18 ± 4
L- C a r n i t i n e 1 8±6 2 0±4 1 9±4
LDH (IU/L) Placebo 150 ± 11 165 ± 15 156 ± 14
Citric acid 151 ± 13 161 ± 15 153 ± 18
L-Carnitine 154 ± 11 171 ± 14 158 ± 14
VAS, visual analogue scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart
rate; TP, total protein; BUN, blood urea nitrogen; CPK, creatine phosphokinase; AST, aspartate ami-
notransferase; LDH, lactate dehydrogenase.
Data are presented as mean ± SD.
**p<0.01, significantly different from the corresponding values of the placebo group (paired t test
with Bonferroni correction).T. Sugino et al.
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Table 3. Effects of citric acid and L-Carnitine on metabolic and hormonal parameters
Before (0 h) After (4 h) Recovery (8 h)
Glucose (mmol/L) Placebo 5.5 ± 0.4 4.8 ± 0.4 6.2 ± 1.2
Citric acid 5.3 ± 0.6 4.7 ± 0.4 6.3 ± 0.9
L-Carnitine 5.4 ± 0.3 4.8 ± 0.3 6.1 ± 0.8
Lactate (mmol/L) Placebo 0.79 ± 0.54 0.94 ± 0.43 0.93 ± 0.31
Citric acid 0.80 ± 0.55 0.92 ± 0.41 0.90 ± 0.24
L-Carnitine 0.80 ± 0.42 0.90 ± 0.28 0.84 ± 0.20
TG (mg/dL) Placebo 87 ± 44 86 ± 39 59 ± 28
Citric acid 89 ± 54 86 ± 49 62 ± 41
L-Carnitine 93 ± 68 93 ± 57 63 ± 41
FFA (mEq/L) Placebo 0.29 ± 0.15 1.46 ± 0.45 0.07 ± 0.08
Citric acid 0.29 ± 0.14 1.47 ± 0.53 0.04 ± 0.03
L-Carnitine 0.26 ± 0.08 1.48 ± 0.44 0.04 ± 0.02
KB (µmol/l) Placebo 38 ± 25 595 ± 246 18 ± 11
Citric acid 51 ± 46 664 ± 250 16 ± 5
L-Carnitine 44 ± 40 681 ± 263 18 ± 6
AA (µmol/L) Placebo 11 ± 5 118 ± 55 11 ± 6
Citric acid 15 ± 10 134 ± 57 10 ± 3
L-Carnitine 13 ± 7 134 ± 53 12 ± 5
3-OHBA (µmol/L) Placebo 27 ± 20 477 ± 195 7 ± 6
Citric acid 36 ± 36 530 ± 196 6 ± 3
L-Carnitine 31 ± 34 547 ± 216 6 ± 2
Cortisol (nmol/L) Placebo 533.8 ± 125.0 373.8 ± 165.7 365.5 ± 187.6
Citric acid 481.8 ± 107.5 385.0 ± 175.2 314.0 ± 101.1
L-Carnitine 493.8 ± 117.2 390.7 ± 171.8 302.7 ± 122.3
ACTH (pmol/L) Placebo 7.7 ± 4.2 6.2 ± 2.3 4.9 ± 2.4
Citric acid 7.4 ± 4.5 6.8 ± 3.5 3.6 ± 2.0
L-Carnitine 6.8 ± 2.6 7.6 ± 6.3 3.8 ± 2.0
Citric acid (µmol/L) Placebo 81.0 ± 25.6 109.0 ± 29.2 68.0 ± 19.4
Citric acid 83.3 ± 27.4 116.0 ± 35.1 70.3 ± 21.3
L-Carnitine 81.0 ± 21.3 113.3 ± 26.3 70.0 ± 19.2
Total carnitine (µmol/L) Placebo 63 ± 11 65 ± 12 59 ± 11
Citric acid 64 ± 10 64 ± 11 58 ± 10
L-Carnitine 78 ± 10** 96 ± 12** 80 ± 11**
L-Carnitine (µmol/L) Placebo 54 ± 10 43 ± 8 52 ± 10
Citric acid 54 ± 9 42 ± 8 52 ± 9
L-Carnitine 66 ± 12** 61 ± 11** 70 ± 9**
Acyl-carnitine (µmol/L) Placebo 9 ± 2 22 ± 5 7 ± 2
Citric acid 10 ± 4 22 ± 5 6 ± 3
L-Carnitine 12 ± 3* 34 ± 6** 10 ± 4**
CGA/TP (pmol/mg) Placebo 1.858 ± 0.629 1.324 ± 0.997 0.969 ± 0.630
Citric acid 1.192 ± 0.491** 1.017 ± 1.127 0.920 ± 0.631
L-Carnitine 1.480 ± 0.456 1.127 ± 0.665 0.978 ± 0.487
TG, triglyceride; FFA, free fatty acids; KB, ketone bodies; AA, acetoacetic acid; 3-OHBA, 3-
hydroxybutyric acid; ACTH, adrenocorticotropic hormone; CGA/TP, chromogranin A/total protein
ratio.
Data are presented as mean ± SD.
**p<0.01, *p<0.05, significantly different from the corresponding values of the placebo group
(paired t-test with Bonferroni correction).Citric acid, L-carnitine and physical fatigue
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one week reduces the pre-physical load level of salivary
chromogranin A. Chromogranin A was first identified as the
soluble protein discovered in adrenal chromaffin granules
[20] and was later found to exist in various endocrine organs
and sympathetic neurons [21]. Chromogranin A is released
into the extra-cellular matrix with catecolamines and released
into saliva by physiological stress. Our present results may
indicate that citric acid reduces the physiological stress
before the physical exertion and attenuates the subjective
fatigue feeling that our subjects reported on the visual
analogue scale.
The administration of another substance, L-carnitine, for
8 days failed to cause any significant differences at all
time points for all physiological or biochemical markers
investigated except for serum L-carnitine and acylcarnitine
levels. However, it is possible that the test schedule or dose
used in the present study may not have been suitable for
investigating the anti-fatigue effects of L-carnitine. Although
there was a small rise in the serum concentration of L-
carnitine and acylcarnitine in the L-carnitine group, a longer
administration may have induced a further rise of carnitine
in serum and thereby exert a stringer effect. Indeed, it is
known that there seems to be carnitine pool in a human body
and therefore it usually takes more than a month for serum
carnitine levels to reach the plateau. Moreover, the previous
studies were performed at 1–3 g /day administration for 1–8
weeks [13, 14], so further study involving higher dose and
longer period of carnitine administration may be required.
We demonstrated that oral citric acid improved the
subjective fatigue feeling during a fatigue-inducing workload
test and reduced physiological stress. To avoid long-term
fatigue, it is important to develop effective strategies that
attenuate fatigue; citric acid use may prevent the unfavorable
consequences of accumulated physical fatigue.
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